Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches

Published:2020-03 Issue: Volume:473 Page:25-32
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Tagliamonte Maria,Mauriello Angela,Cavalluzzo Beatrice,Ragone Concetta,Manolio Carmen,Petrizzo Annacarmen,Buonaguro Luigi

Funder

Cancer Vaccine development for Hepatocellular Carcinoma – HEPAVAC

Transcan2 – HEPAMUT project

Italian Ministry of Health through Institutional “Ricerca Corrente

Campania OncoTerapie

HEPAVAC

“Ricerca Corrente”

POR FESR

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference109 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2018

2. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial;Llovet;Lancet,2002

3. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival;Llovet;Hepatology,2003

4. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CircGNAO1 strengthens its host gene GNAO1 expression for suppression of hepatocarcinogenesis;Heliyon;2024-06

2. TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma;Journal for ImmunoTherapy of Cancer;2023-11

3. Radiomics in the diagnosis and treatment of hepatocellular carcinoma;Hepatobiliary & Pancreatic Diseases International;2023-08

4. CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach;Journal of Nanobiotechnology;2023-05-20

5. CAR T-cell therapy: Reprogramming patient's immune cell to treat cancer;Cellular Signalling;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3